Hypertensive bipolar: chronic lithium toxicity in patients taking ACE inhibitor

BMJ Case Rep. 2017 Aug 28:2017:bcr2017220631. doi: 10.1136/bcr-2017-220631.

Abstract

A patient with bipolar I disorder has been treated with lithium and haloperidol for the last 20 years and received an ACE inhibitor for his hypertension since 9 years ago. Despite regular clinic follow-ups and blood monitoring, he recently developed tremors and delirium. On hospital admission, serum level of lithium was far above toxic level. Mental state examination revealed an anxious and disorientated man with irrelevant speech. Immediate discontinuation of lithium resulted in slow reduction of serum lithium levels and gradual resolution of tremor but his delirium persisted for 2 weeks. His condition took a turn for the worse when he developed acute renal failure and arm abscess. We discussed about lithium toxicity and the vulnerability factors which have induced delirium and renal failure in this patient.

Keywords: acute renal failure; drug interactions; psychiatry; psychiatry (drugs and medicines).

Publication types

  • Case Reports

MeSH terms

  • Acute Kidney Injury / chemically induced
  • Acute Kidney Injury / complications
  • Angiotensin-Converting Enzyme Inhibitors / therapeutic use*
  • Bipolar Disorder / complications*
  • Bipolar Disorder / drug therapy
  • Delirium / chemically induced*
  • Delirium / complications
  • Diagnosis, Differential
  • Drug Interactions
  • Haloperidol / therapeutic use
  • Humans
  • Hypertension / drug therapy*
  • Lithium / blood
  • Lithium / therapeutic use
  • Lithium / toxicity*
  • Male
  • Middle Aged
  • Treatment Outcome

Substances

  • Angiotensin-Converting Enzyme Inhibitors
  • Lithium
  • Haloperidol